Treatment of Hepatorenal Syndrome-Acute Kidney Injury: Advances Made but Challenges Remain.
作者信息
Premkumar Madhumita, Reddy K Rajender
机构信息
Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
出版信息
Gastro Hep Adv. 2023 Feb 17;2(4):547-548. doi: 10.1016/j.gastha.2023.02.005. eCollection 2023.
Abstract
摘要
相似文献
1
Treatment of Hepatorenal Syndrome-Acute Kidney Injury: Advances Made but Challenges Remain.肝肾综合征-急性肾损伤的治疗：虽有进展，但挑战犹存。
Gastro Hep Adv. 2023 Feb 17;2(4):547-548. doi: 10.1016/j.gastha.2023.02.005. eCollection 2023.
2
MODIFIED TREATMENT OF HEPATORENAL SYNDROME TYPE I DEPENDING ON THE STAGE OF ACUTE KIDNEY INJURY.根据急性肾损伤分期对肝肾综合征 I 型的改良治疗。
Georgian Med News. 2021 May(314):125-128.
3
Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study.肝硬化患者急性肾损伤和肝肾综合征的预后：一项前瞻性队列研究。
Int J Nephrol. 2015;2015:108139. doi: 10.1155/2015/108139. Epub 2015 Jul 22.
4
Hepatorenal Syndrome With Acute Kidney Injury: Diagnosis and Medical Management.肝肾综合征合并急性肾损伤：诊断与药物治疗
Ann Pharmacother. 2024 Feb;58(2):156-164. doi: 10.1177/10600280231177698. Epub 2023 Jun 4.
5
Hepatorenal Syndrome.肝肾综合征。
Clin J Am Soc Nephrol. 2019 May 7;14(5):774-781. doi: 10.2215/CJN.12451018. Epub 2019 Apr 17.
6
[Management of renal injury include hepatorenal syndrome in patients with decompensated liver cirrhosis].[失代偿期肝硬化患者肝肾综合征等肾损伤的管理]
Zhonghua Gan Zang Bing Za Zhi. 2020 May 20;28(5):381-385. doi: 10.3760/cma.j.cn501113-20200427-00216.
7
Prevalence of Acute Kidney Injury in Patients with Liver Cirrhosis.肝硬化患者急性肾损伤的患病率。
JNMA J Nepal Med Assoc. 2020 Aug 31;58(228):554-559. doi: 10.31729/jnma.5147.
8
Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies.肝硬化患者的肾衰竭：肝肾综合征和肾脏支持策略。
Curr Opin Anaesthesiol. 2010 Apr;23(2):139-44. doi: 10.1097/ACO.0b013e32833724a8.
9
Hepatorenal syndrome: pathophysiology, diagnosis, and management.肝肾综合征：病理生理学、诊断与治疗。
BMJ. 2020 Sep 14;370:m2687. doi: 10.1136/bmj.m2687.
10
Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function.特利加压素治疗肾功能快速下降的肝肾综合征成人患者的相关治疗费用分析。
Adv Ther. 2023 Dec;40(12):5432-5446. doi: 10.1007/s12325-023-02674-z. Epub 2023 Oct 9.
引用本文的文献
1
Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population.在移植人群中，持续特利加压素输注治疗肝肾综合征伴急性肾损伤的安全性和有效性。
Liver Transpl. 2024 Oct 1;30(10):1026-1038. doi: 10.1097/LVT.0000000000000399. Epub 2024 May 22.
本文引用的文献
1
Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure.特利加压素在 1 型肝肾综合征和严重急性慢性肝衰竭患者中的应用与呼吸衰竭。
Aliment Pharmacol Ther. 2022 Oct;56(8):1284-1293. doi: 10.1111/apt.17195. Epub 2022 Aug 22.
2
Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study.特利加压素治疗伴有肝肾综合征-急性肾损伤（HRS-AKI）的慢加急性肝衰竭患者的安全性和有效性：一项前瞻性队列研究。
Sci Rep. 2022 Apr 1;12(1):5503. doi: 10.1038/s41598-022-09505-1.
3
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.特利加压素联合白蛋白治疗 1 型肝肾综合征。
N Engl J Med. 2021 Mar 4;384(9):818-828. doi: 10.1056/NEJMoa2008290.
4
Left Ventricular Diastolic Dysfunction is Associated with Renal Dysfunction, Poor Survival and Low Health Related Quality of Life in Cirrhosis.左心室舒张功能障碍与肝硬化患者的肾功能不全、生存率低及健康相关生活质量差有关。
J Clin Exp Hepatol. 2019 May-Jun;9(3):324-333. doi: 10.1016/j.jceh.2018.08.008. Epub 2018 Aug 30.
5
Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure.特利加压素在慢性肝衰竭急性加重期急性肾损伤管理中优于去甲肾上腺素。
Hepatology. 2020 Feb;71(2):600-610. doi: 10.1002/hep.30208. Epub 2019 Feb 20.
6
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.急慢性肝衰竭程度与肝肾综合征患者特利加压素和白蛋白反应的关系。
Clin Gastroenterol Hepatol. 2018 Nov;16(11):1792-1800.e3. doi: 10.1016/j.cgh.2018.01.035. Epub 2018 Jan 31.
7
Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study.特利加压素持续静脉输注与静脉推注治疗肝肾综合征的随机对照研究。
Hepatology. 2016 Mar;63(3):983-92. doi: 10.1002/hep.28396. Epub 2016 Feb 3.
8
Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage.特利加压素、生长抑素和奥曲肽在控制急性胃食管静脉曲张出血方面无差异。
Hepatology. 2014 Sep;60(3):954-63. doi: 10.1002/hep.27006. Epub 2014 Jul 25.
9
Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.预测肝硬化伴 1 型肝肾综合征患者应用特利加压素和白蛋白治疗反应的因素。
Hepatology. 2010 Jan;51(1):219-26. doi: 10.1002/hep.23283.
Zotero 插件